Incobotulinum Toxin A – March 2026

• Brand names:
  • Xeomin®
• Pharmaceutical Company:
  • MERZ AUSTRALIA PTY LTD
• Condition/Indication: Moderate to severe spasticity of the lower limb in adults following an acute event
• Meeting Date: March 2026
• Public Summary Document (PSD) March 2026 PBAC Meeting - (PDF)
• Public Summary Document (PSD) March 2026 PBAC Meeting - (DOCX)